Search

Your search keyword '"Tan,Shuilian"' showing total 16 results
Start Over Author "Tan,Shuilian"
16 results on '"Tan,Shuilian"'

1. A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study

Author

Wang, Zhen, Yao, Jundong, Jing, Xiang, Li, Kaiyan, Lu, ShiChun, Yang, Hong, Ding, Hong, Li, Kai, Cheng, Wen, He, Guangzhi, Jiang, Tianan, Liu, Fangyi, Yu, Jie, Han, Zhiyu, Cheng, Zhigang, Tan, Shuilian, Wang, Zhen, Qi, Erpeng, Wang, Shuo, Zhang, YiQiong, Li, Lu, Dong, Xiaocong, Liang, Ping, and Yu, Xiaoling

Published
2024
Full Text
View/download PDF

2. Correction: Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study

Author

Zhao, Qin-xian, Wu, Chong, Tan, Shuilian, Yang, Yongfeng, Cui, Xin-Wu, Dietrich, Christoph F., Yang, Bin, Xu, Chao-li, Gao, Yong-yan, Xie, Ming-xing, Wu, Chang-jun, Liu, Li-ping, Wang, Xing-hua, Ling-hu, Run-ze, Wang, Ning, Wang, Fei, Wang, Xiu-li, Liu, Guo-yan, Yu, Xiao-ling, Yu, Jie, Cheng, Zhi-gang, and Liang, Ping

Published
2024
Full Text
View/download PDF

3. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study

Author

Zhao, Qin-xian, Wu, Chong, Tan, Shuilian, Yang, Yongfeng, Cui, Xin-Wu, Dietrich, Christoph F., Yang, Bin, Xu, Chao-li, Gao, Yong-yan, Xie, Ming-xing, Wu, Chang-jun, Liu, Li-ping, Wang, Xing-hua, Ling-hu, Run-ze, Wang, Ning, Wang, Fei, Wang, Xiu-li, Liu, Guo-yan, Yu, Xiao-ling, Yu, Jie, Cheng, Zhi-gang, and Liang, Ping

Published
2024
Full Text
View/download PDF

4. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study

Author

Wang, Shuo, Yao, Jundong, Li, Kaiyan, Yang, Hong, Lu, Shichun, He, Guangzhi, Wu, Wei, Cheng, Wen, Jiang, Tianan, Ding, Hong, Jing, Xiang, Yan, Yuanyuan, Liu, Fangyi, Yu, Jie, Han, Zhiyu, Cheng, Zhigang, Tan, Shuilian, Li, Xin, Dou, Jianping, Li, Yunlin, Qi, Erpeng, Zhang, Yiqiong, Liang, Ping, and Yu, Xiaoling

Published
2023
Full Text
View/download PDF

5. Analysis of Sonazoid contrast-enhanced ultrasound for predicting the risk of microvascular invasion in hepatocellular carcinoma: a prospective multicenter study

Author

Yao, Jundong, Li, Kaiyan, Yang, Hong, Lu, Shichun, Ding, Hong, Luo, Yan, Li, Kai, Xie, Xiaoyan, Wu, Wei, Jing, Xiang, Liu, Fangyi, Yu, Jie, Cheng, Zhigang, Tan, Shuilian, Dou, Jianping, Dong, XueJuan, Wang, Shuo, Zhang, Yiqiong, Li, Yunlin, Qi, Erpeng, Han, Zhiyu, Liang, Ping, and Yu, XiaoLing

Published
2023
Full Text
View/download PDF

8. Ultrasound-guided percutaneous microwave ablation of bilateral renal cell carcinomas: Focus upon safety and efficacy

Author

Zhang, Ruimin, Qi, Erpeng, Liang, Ping, Cheng, Zhigang, Tan, Shuilian, Han, Zhiyu, Liu, Fangyi, Yu, Jie, and Yu, Xiaoling

Subjects
Radiofrequency ablation -- Methods -- Patient outcomes, Ultrasound imaging -- Usage, Carcinoma, Renal cell -- Development and progression -- Care and treatment, Health
Abstract

Byline: Ruimin. Zhang, Erpeng. Qi, Ping. Liang, Zhigang. Cheng, Shuilian. Tan, Zhiyu. Han, Fangyi. Liu, Jie. Yu, Xiaoling. Yu Objective: To retrospectively review the safety and efficacy of ultrasound (US)-guided [...]

Published
2021

10. The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer

Author

Hu,Yanyan, Qi,Erpeng, Liu,Fangyi, Lu,Yuhan, Tan,Shuilian, Sun,Ya, Han,Zhiyu, Liang,Ping, and Yu,Xiaoling

Subjects
pancreatic cancer, intraoperative implantation, ultrasound-guided, OncoTargets and Therapy, Original Research, 125I seed, three-dimensional visualization
Abstract

Yanyan Hu,1,2 Erpeng Qi,1 Fangyi Liu,1 Yuhan Lu,1 Shuilian Tan,1 Ya Sun,1 Zhiyu Han,1 Ping Liang,1 Xiaoling Yu1 1Department of Interventional Ultrasound, General Hospital of People’s Liberation Army, Beijing, China; 2Medical Department, First Affiliated Hospital of PLA General Hospital, Beijing, China Objectives: To evaluate the effectiveness of iodine-125 (125I) seed implantation for pancreatic cancer (PC), and preliminarily evaluate the clinical value of a self-developed three-dimensional (3D) visualized seed planning and navigation system in 125I seed implantation for treatment of PC. Patients and methods: Our team retrospectively reviewed 25 PC patients who underwent 125I seed implantation between December 2010 and November 2016. The patients were divided into two groups: 3D visualization preoperative planning group (12 patients, 13 lesions) and two-dimensional (2D) regular group (13 patients, 14 lesions). We compared and analyzed the parameters of the two groups, such as number of needle insertions, one-time treatment success rate, proportion of added seeds, local control rate, rate of complications, rate of pain relief, and the survival rate and risk factors of the two groups. There was no significant difference in clinical data of the two groups. Results: 125I seed implantation was performed successfully in all PC patients, with no occurrence of serious complications during and after the procedure. The one-time treatment success rate of 3D group (80%) was higher than that of 2D group (45.5%) (P

Published
2018

12. Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients

Author

Sun,Ya, Zhou,Fubo, Liu,Fangyi, Hu,Yanyan, Tan,Shuilian, Liang,Ping, Linghu,Enqiang, Yu,Xiaoling, Sun,Ya, Zhou,Fubo, Liu,Fangyi, Hu,Yanyan, Tan,Shuilian, Liang,Ping, Linghu,Enqiang, and Yu,Xiaoling

Abstract

Ya Sun,1,* Fubo Zhou,1,* Fangyi Liu,1 Yanyan Hu,1 Shuilian Tan,1 Ping Liang,1 Enqiang Linghu,2 Xiaoling Yu1 1Department of Interventional Ultrasound, 2Department of Gastroenterology, Chinese PLA General Hospital, Beijing, People’s Republic of China *These authors contributed equally to this work Objectives: The preoperative diagnosis between serous cystadenomas (SCAs) and mucinous cystadenomas (MCAs) in pancreas is significant due to their completely different biological behaviors. The purpose of our study was to examine and compare detailed contrast-enhanced ultrasonography (CEUS) images of SCAs and MCAs and to determine whether there are significant findings that can contribute to the discrimination between these two diseases. Methods: From April 2015 to June 2016, 61 patients (35 patients with SCAs and 26 patients with MCAs) were enrolled in this study. Forty-three cases were confirmed by surgical pathology and 18 by comprehensive clinical diagnoses. All of the CEUS characteristics of these lesions were recorded: size, location, echogenicity, shape, wall characteristics, septa characteristics, and the presence of a honeycomb pattern or nodules. CEUS examinations were performed by two ultrasound physicians. Results: Location (P=0.003), shape (P=0.000), thickness of the wall (P=0.005), the number of septa (P=0.001), and the honeycomb pattern (P=0.001) were statistically significantly different. A head–neck location, a lobulated shape, an inner regular honeycomb pattern, and a thin wall (<3 mm thick) were significant in diagnosing patients with SCAs. When two of these four findings were combined, we could achieve a sensitivity of 71.4% and a specificity of 80.8% to diagnose SCA; when three of these four findings were combined, the specificity was 100%. A body–tail location, a round/oval shape, 0–2 septa, and a thick wall (≥3 mm thick) were most often detected in patients with MCAs. When two of these four findings

Published
2017

15. The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer.

Author

Hu, Yanyan, Qi, Erpeng, Liu, Fangyi, Lu, Yuhan, Tan, Shuilian, Sun, Ya, Han, Zhiyu, Liang, Ping, and Yu, Xiaoling

Subjects
PANCREATIC cancer diagnosis, MEDICAL imaging systems, THREE-dimensional imaging, TREATMENT effectiveness, PANCREATIC cancer treatment, SURVIVAL analysis (Biometry)
Abstract

Objectives: To evaluate the effectiveness of iodine-125 (125I) seed implantation for pancreatic cancer (PC), and preliminarily evaluate the clinical value of a self-developed three-dimensional (3D) visualized seed planning and navigation system in 125I seed implantation for treatment of PC. Patients and methods: Our team retrospectively reviewed 25 PC patients who underwent 125I seed implantation between December 2010 and November 2016. The patients were divided into two groups: 3D visualization preoperative planning group (12 patients, 13 lesions) and two-dimensional (2D) regular group (13 patients, 14 lesions). We compared and analyzed the parameters of the two groups, such as number of needle insertions, one-time treatment success rate, proportion of added seeds, local control rate, rate of complications, rate of pain relief, and the survival rate and risk factors of the two groups. There was no significant difference in clinical data of the two groups. Results: 125I seed implantation was performed successfully in all PC patients, with no occurrence of serious complications during and after the procedure. The one-time treatment success rate of 3D group (80%) was higher than that of 2D group (45.5%) (P,0.05), and the proportion of added seed number of 3D group was lower than that of 2D group (P,0.05). The local control rate of 3D group (76.9%) was higher than that of 2D group (35.7%) (P,0.05). The survival rate of 3D group was significantly higher than that of 2D group (P=0.026), and the median survival of 2D group vs 3D group was 5.00 vs 10.80 months. The median survival of all 25 patients was 7.10 months (95% confidence interval: 4.43-9.77). The rate of pain relief was 77.8% (7/9) in 2D group and 88.9% (8/9) in 3D group. Conclusion: Ultrasound-guided, 3D visualized seed planning and navigation system assisted 125I seed implantation is a safe and effective method for the treatment of PC, with a prolonged survival of patients and better local control of tumor. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

16. The application of a three-dimensional visualized seed planning and navigation system in 125 I seed implantation for pancreatic cancer.

Author

Hu Y, Qi E, Liu F, Lu Y, Tan S, Sun Y, Han Z, Liang P, and Yu X

Abstract

Objectives: To evaluate the effectiveness of iodine-125 ( 125 I) seed implantation for pancreatic cancer (PC), and preliminarily evaluate the clinical value of a self-developed three-dimensional (3D) visualized seed planning and navigation system in 125 I seed implantation for treatment of PC., Patients and Methods: Our team retrospectively reviewed 25 PC patients who underwent 125 I seed implantation between December 2010 and November 2016. The patients were divided into two groups: 3D visualization preoperative planning group (12 patients, 13 lesions) and two-dimensional (2D) regular group (13 patients, 14 lesions). We compared and analyzed the parameters of the two groups, such as number of needle insertions, one-time treatment success rate, proportion of added seeds, local control rate, rate of complications, rate of pain relief, and the survival rate and risk factors of the two groups. There was no significant difference in clinical data of the two groups., Results: 125 I seed implantation was performed successfully in all PC patients, with no occurrence of serious complications during and after the procedure. The one-time treatment success rate of 3D group (80%) was higher than that of 2D group (45.5%) ( P <0.05), and the proportion of added seed number of 3D group was lower than that of 2D group ( P <0.05). The local control rate of 3D group (76.9%) was higher than that of 2D group (35.7%) ( P <0.05). The survival rate of 3D group was significantly higher than that of 2D group ( P =0.026), and the median survival of 2D group vs 3D group was 5.00 vs 10.80 months. The median survival of all 25 patients was 7.10 months (95% confidence interval: 4.43-9.77). The rate of pain relief was 77.8% (7/9) in 2D group and 88.9% (8/9) in 3D group., Conclusion: Ultrasound-guided, 3D visualized seed planning and navigation system assisted 125 I seed implantation is a safe and effective method for the treatment of PC, with a prolonged survival of patients and better local control of tumor., Competing Interests: Disclosure All of the authors report no conflicts of interest in this work.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results